MAGNIFY BIOSCIENCES INC.
Medtech · Private
Automated expansion microscopy device that enables nanoscale bioimaging on conventional optical microscopes
- Grants
- $1.2M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Unlocking the Full Potential of Next-Generation Expansion Microscopy through Automation | $274,998 | |
| Federal grant | Department of Health and Human Services · Phase I · Multiplex Magnify Protocol and Kit for High Plex, Superresolution 3D Synaptic Imaging and Analysis in Neuroscience | $457,026 | |
| Federal grant | Department of Health and Human Services · Phase I · Multiplex Magnify Protocol and Kit for High Plex, Superresolution 3D Synaptic Imaging and Analysis in Neuroscience | $451,095 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2027 | CCJ Medical Devices LLC | — | — |
| 2028 | ERGAMI ENDOSCOPY, INC. | — | — |
| 2029 | CALIBERMRI INC | — | — |
| 2030 | MAGNIFY BIOSCIENCES INC. | — | — |
| 2031 | Cumulus | — | — |
| 2032 | QSCINT IMAGING SOLUTIONS, LLC | — | — |
| 2033 | FLEX ORTHOPAEDICS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.